Dermata Therapeutics Warrant
DRMAW
3 hedge funds and large institutions have $60.5K invested in Dermata Therapeutics Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
709% more capital invested
Capital invested by funds: $7.48K → $60.5K (+$53K)
1.34% less ownership
Funds ownership: 2.59% → 1.25% (-1.3%)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$232 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12 |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $60.2K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $225 | -$11 | -547 | -5% |
|
|
3
UBS Group
Zurich,
Switzerland
| $22 | -$12 | -601 | -32% |
|
|
TSS
4
Two Sigma Securities
New York
| – | -$232 | -13,115 | Closed |
|
DRMAW Hedge Fund Activity: Q3 2025 in Review
3 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Dermata Therapeutics Warrant (DRMAW) for Q3 2025, worth a combined $60.5K — up 709% from $7.48K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DRMAW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Two Sigma Securities, exiting entirely with an estimated $232 sold.
- 3 institutional investors held Dermata Therapeutics Warrant (DRMAW) as of Q3 2025, down from 5 in Q2 2025.
- Funds reported $60.5K of Dermata Therapeutics Warrant stock for Q3 2025, up 709% quarter-over-quarter.
- 0 funds opened new Dermata Therapeutics Warrant positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest Dermata Therapeutics Warrant seller in Q3 2025 was Two Sigma Securities, an estimated $232 sold.
Based on aggregated 13F filings for Q3 2025.